Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Drugs Dermatol. 2006 Oct;5(9):868-70.

Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.

Author information

  • 1Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. wpbowe@mail.med.upenn.edu

Abstract

We report the in vitro inhibition of Propionibacterium acnes (P. acnes) by a bacteriocin-like inhibitory substance (BLIS-like substance) produced by Streptococcus salivarius (S. salivarius). Bacteriocins are proteinaceous substances produced by bacteria that are capable of inhibiting the growth of similar bacterial strains. Unlike classical antibiotics, they have a relatively narrow spectrum of killing activity, resulting in a reduction in the intensity of selection for resistance. These findings suggest that BLIS may potentially be used for its anti-P. acnes activity in the treatment of acne.

PMID:
17039652
[PubMed - indexed for MEDLINE]
PMCID:
PMC2739725
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk